Ultralife Corporation
ULBI
$5.68
-$0.09-1.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.94% | 5.86% | 2.74% | 3.66% | 9.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.94% | 5.86% | 2.74% | 3.66% | 9.95% |
| Cost of Revenue | 16.27% | 8.34% | 3.35% | 2.26% | 6.74% |
| Gross Profit | 3.54% | -1.14% | 0.96% | 7.94% | 20.17% |
| SG&A Expenses | 20.71% | 15.31% | 12.37% | 8.50% | 2.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.61% | 10.11% | 5.57% | 3.57% | 5.97% |
| Operating Income | -44.60% | -42.01% | -29.80% | 5.17% | 105.03% |
| Income Before Tax | -78.91% | -64.21% | -45.88% | -8.95% | 94.15% |
| Income Tax Expenses | -69.99% | -49.40% | -36.99% | -3.02% | 23.48% |
| Earnings from Continuing Operations | -80.78% | -67.55% | -48.26% | -10.56% | 120.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 51.43% | -600.00% | -437.93% | -412.90% | -488.89% |
| Net Income | -80.89% | -68.24% | -49.34% | -12.30% | 119.29% |
| EBIT | -44.60% | -42.01% | -29.80% | 5.17% | 105.03% |
| EBITDA | -25.09% | -26.96% | -19.46% | 5.50% | 62.88% |
| EPS Basic | -81.11% | -68.67% | -50.30% | -13.65% | 115.70% |
| Normalized Basic EPS | -69.32% | -57.49% | -39.96% | 4.97% | 66.64% |
| EPS Diluted | -81.95% | -69.17% | -50.06% | -12.01% | 119.63% |
| Normalized Diluted EPS | -69.12% | -57.27% | -40.36% | 4.02% | 65.03% |
| Average Basic Shares Outstanding | 0.93% | 1.50% | 2.06% | 2.11% | 1.98% |
| Average Diluted Shares Outstanding | 0.07% | 1.28% | 2.59% | 2.95% | 3.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |